Biology & Medicine News and Discussions

weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Bug-inspired coating could make for better bone and joint implants
By Michael Franco
May 09, 2023
https://newatlas.com/medical/bug-inspir ... -implants/
Inspired by the wings of dragonflies and cicadas, researchers have developed a new coating for orthopedic implants. It not only shreds harmful bacteria, but also monitors stress on the system, meaning it could warn of impending implant failure.

Biomimicry, the practice of creating man-made items based on observations of the natural world, has been a powerful driver of innovations in the medical community for years. We've seen a material that could make for better bone implants inspired by the different types of pores found in wood and animal horns; a cactus-inspired sensor that can collect sweat for analysis; and a coating for brain implants based on the leaves of the carnivorous pitcher plant.

Turning to nature once again for a coating solution, researchers at University of Illinois Urbana-Champaign (UI) looked to the bacteria-fighting wings of dragonflies and cicadas to solve a persistent problem that arises from orthopedic implants: infection.
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Two-for-one treatment: Antidepressant agent found to also reduce stress
By Paul McClure
May 08, 2023
https://newatlas.com/science/antidepres ... s-as-well/
Stress and depression often go hand-in-hand. Now, novel research has shown that a known antidepressant agent, KNT-127, also reduces stress, providing insight into the physiological processes underpinning depression, and has potential for new treatments.

Psychological stress is a major driver of mental illness such as depression, a common condition that affects millions of people worldwide. But the association between psychological stress and depression is unclear.

Previous studies into the link between stress and mental health have used animal models to look at the effect of physical stress on depression, rather than analyzing psychological stress. A new study out of Japan has used a depression mouse model to focus only on animals repeatedly exposed to psychological stress.

For their study, researchers at the Tokyo University of Science tested the effectiveness of KNT-127, a delta opioid agonist, in treating depression in mice.

The opioid system, in addition to playing a central role in pain control, regulates the body’s stress response. Delta opioid receptors (DOPs) in the brain and nervous system have long been known to feature prominently in emotional processing. Genetic studies have shown that knocking out the DOP-encoding gene leads to higher anxiety-related responses and depression-like behaviors.

DOP agonists block the action of delta opioid receptors. Previous studies have demonstrated that KNT-127, a DOP agonist, is an effective antidepressant, producing fewer side effects than existing antidepressant drugs.

“We previously discovered that delta opioid receptor (DOP) agonists may [have a] quick action and have a low risk of side effects compared to existing drugs,” said Akiyoshi Saitoh, corresponding author of the study. “Thus, we have been working on their clinical development as a new treatment strategy for depression.”
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Making vaccines longer lasting: Findings could revolutionize how all vaccines could be made to last longer
https://medicalxpress.com/news/2023-05- ... onize.html
by Monash University
The SARS-Cov-2 pandemic illustrates how variable vaccines can be in their length of efficacy, with regular boosters needed to keep people protected. In comparison, the immunity generated by a single vaccination against the measles virus can last decades.

It has always remained a scientific mystery as to why only some vaccines lead to life-long protection. Now a paper published in the journal, Immunity, led by Prof. David Tarlinton and Dr. Marcus Robinson, both from Monash University's Central Clinical School in Melbourne, Australia, has found that the clue likely lies in the body producing a unique subtype of an immune cell in response to some but not other vaccinations. The finding could revolutionize how all vaccines could be made to be longer lasting.

Vaccines trick our immune cells into thinking the body has been infected. In response, we produce antibodies to fight off what is perceived as an infection. According to Dr. Robinson, "most vaccines work by generating high levels of antibodies against these invaders, but how long these antibodies persist in the body is highly variable by vaccine," he said. "Now we know that the clue is in whether vaccines generate a special subtype of immune cell that produces antibody for long times to fight off infection indefinitely."
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

New breathalyzer for disease sniffs out COVID in real-time, could be used to detect cancer, lung disease
https://phys.org/news/2023-05-breathaly ... ancer.html
by Lisa Marshall, University of Colorado at Boulder
With each breath, humans exhale more than 1,000 distinct molecules, producing a unique chemical fingerprint or "breathprint" rich with clues about what's going on inside the body.

For decades, scientists have sought to harness that information, turning to dogs, rats and even bees to literally sniff out cancer, diabetes, tuberculosis and more.

Scientists from CU Boulder and the National Institute of Standards and Technology (NIST) have made an important leap forward in the quest to diagnose disease using exhaled breath, reporting that a new laser-based breathalyzer powered by artificial intelligence (AI) can detect COVID-19 in real-time with excellent accuracy.

The results were published April 5 in the Journal of Breath Research.
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Skin patch could help ease peanut allergy in toddlers
https://medicalxpress.com/news/2023-05- ... lergy.html
by Amy Norton
A "peanut patch" worn on the skin may help protect toddlers who have potentially life-threatening peanut allergies, a new clinical trial shows.

The patch is a form of immunotherapy, which means it exposes peanut-allergic children to tiny bits of peanut protein over time—with the goal of training the immune system to better tolerate it.

In the trial, researchers found that of toddlers who wore the peanut patch every day for a year, two-thirds showed a significant reduction in their sensitivity to peanut protein: They were able to eat the equivalent of one to four peanuts without suffering an allergic reaction.

While that might sound like peanuts, experts said that level of tolerance is important.

The goal of immunotherapy is to prevent a severe reaction should a child accidentally ingest a small amount of peanut, said Dr. Alkis Togias, of the U.S. National Institute of Allergy and Infectious Diseases.
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Researchers find compound that combats multidrug-resistant bacteria in less than one hour
https://phys.org/news/2023-05-compound- ... -hour.html
by Ricardo Muniz, FAPESP
Resistance to antibiotics is a problem that alarms the medical and scientific community. Bacteria resistant to three different classes of antibiotics, known as multi-drug resistant (MDR) bacteria, are far from rare. Some are even resistant to all currently available treatments and are known as pan-drug resistant (PDR). They are associated with dangerous infections and listed by the World Health Organization (WHO) as priority pathogens for drug development with maximum urgency.

An article published in a special issue of the journal Antibiotics highlights a compound with antibacterial activity that presented promising results within one hour in laboratory trials.

The study was led by Ilana Camargo, last author of the article, and conducted during the doctoral research of first author Gabriela Righetto at the Molecular Epidemiology and Microbiology Laboratory (LEMiMo) of the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) in Brazil.
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Novel antibiotic succeeds in trial against hospital-acquired pneumonia
https://medicalxpress.com/news/2023-05- ... monia.html
by Rutgers University-New Brunswick
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.

The findings have led a unanimous expert committee to recommend that the Food and Drug Administration (FDA) approve the new drug, which could be available this summer to combat the often-fatal pneumonia strain known as carbapenem-resistant Acinetobacter baumannii–calcoaceticus complex (ABC), typically acquired in hospitals.

"Antibiotic-resistant infections are a serious and persistent problem at healthcare facilities, and the [Centers for Disease Control] ranks ABC at the highest level on its threat list," said Keith Kaye, chief of the Division of Allergy, Immunology and Infectious Disease at Robert Wood Johnson Medical School and first author of the trial report in The Lancet Infectious Diseases. "An estimated 8,500 hospital-acquired cases killed 700 patients and cost $280 million in 2019, so we greatly needed a breakthrough treatment like sulbactam-durlobactam."

The trial gave imipenem–cilastatin to 181 patients with laboratory-confirmed ABC and then randomized them to additional treatment with either sulbactam–durlobactam or the best existing treatment, an antibiotic called colistin. Mortality due to multiple causes after 28 days was 12 of 63 (19 percent) in the sulbactam–durlobactam group and 20 of 62 (32 percent) in the colistin group.

The trial was large enough to prove that sulbactam-durlobactam prevents at least as many fatalities as colistin but not large enough to prove its superiority in this trial will persist in real-world use, though it may.
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Scientists use AI to find promising new antibiotic to fight evasive hospital superbug
https://phys.org/news/2023-05-scientist ... pital.html
by McMaster University

Scientists at McMaster University and the Massachusetts Institute of Technology have used artificial intelligence to discover a new antibiotic that could be used to fight a deadly, drug-resistant pathogen that strikes vulnerable hospital patients.

The process they used could also speed the discovery of other antibiotics to treat many other challenging bacteria.

The researchers were responding to the urgent need for new drugs to treat Acinetobacter baumannii, identified by the World Health Organization as one of the world's most dangerous antibiotic-resistant bacteria. Notoriously difficult to eradicate, A. baumannii can cause pneumonia, meningitis and infect wounds, all of which can lead to death.

A. baumanni is usually found in hospital settings, where it can survive on surfaces for long periods. The pathogen is able to pick up DNA from other species of bacteria in its environment, including antibiotic-resistance genes.

In the study, published today in the journal Nature Chemical Biology, researchers report they used an artificial intelligence algorithm to predict new structural classes of antibacterial molecules, and identified a new antibacterial compound, which they have named abaucin.

Discovering new antibiotics against A. baumannii through conventional screening has been challenging. Traditional methods are time-consuming, costly, and limited in scope.

Modern algorithmic approaches can access hundreds of millions, possibly billions, of molecules with antibacterial properties.
weatheriscool
Posts: 12971
Joined: Sun May 16, 2021 6:16 pm

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Beating seizures by jamming the cellular circuitry
https://medicalxpress.com/news/2023-05- ... uitry.html
by Levi Gadye, University of California, San Francisco
Research at UC San Francisco has shown for the first time how the commonly prescribed seizure and pain medication, gabapentin, acts inside of cells, opening the door to new, more effective treatments for diseases like epilepsy and lupus.

The twin papers, published in Nature on May 17 and Nature Structural & Molecular Biology on March 27, show how gabapentin interacts with ion channels called voltage-gated calcium channels, which are critical to the function of numerous organs, from the heart to the brain to the gut.

"Gabapentin is a very important, widely used drug, but it has many side effects, including dizziness and nausea, and we don't understand how it works," said Daniel Minor, Ph.D., a biophysics professor in the UCSF Cardiovascular Research Institute and the senior author of both papers. "We have shown how gabapentin binds to calcium channels, giving the field the opportunity to design a new generation of therapies."
User avatar
wjfox
Site Admin
Posts: 8732
Joined: Sat May 15, 2021 6:09 pm
Location: London, UK
Contact:

Re: Biology & Medicine News and Discussions

Post by wjfox »

Post Reply